drugset / Trial / NCT00691444

Blind Child Melatonin Treatment Study

NCT00691444

Non-randomizedParallel-groupSingle-blindTreatment

Summary

The primary focus of this five-year study will be to optimize the melatonin dosing regimen for synchronizing the body clocks of blind children to the 24-hour day.

Timeline

Start
2002-09
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule

Indications